Members of the GP2 Operations and Compliance working group provide an overview of what compliance is and why it is important in GP2. The post What is Compliance and Why is it Important? appeared first on Aligning Science Across Parkinson's.| Aligning Science Across Parkinson's
Learn how Longboat is reimagining critical workflows across sites, sponsors, CROs, and patients.| Advarra
Internal IRB reviews are NOT free, contrary to popular belief. In this blog we outline practical steps for assessing and establishing IRB review cost| Advarra
Find out how the EU AI Act will likely impact clinical research software and systems, and what EU and non-EU entities should do to prepare for compliance.| Advarra
Ensure product quality and compliance in the drug development process. Learn how to optimize your manufacturing processes and maintain key regulatory standards with cGMP best practices from experts.| Advarra
Clinical research is complex and resource-intensive, and to understand just how far an organization’s resources can go, assessing a study’s feasibility is critical for success. Evaluating feasibility elements enable organizations to make informed decisions and allows for seamless execution and reporting of clinical studies. How can your organization utilize feasibility to its fullest extent? Defining| Advarra - Advancing Better Research
This checklist offers a comprehensive framework for managing all necessary essential regulatory documents efficiently.| Advarra
Explore key local considerations for developing single IRB policies, and learn how to navigate the challenges- including compliance, ethical standards, and institutional requirements.| Advarra
Ensure GCP compliance throughout your clinical research lifecycle with a comprehensive guide to GxP audits.| Advarra
Working in a multi-disciplinary team is important to deliver great services. Equally, it is important to make time for community. There are lots of ways we work in collaboration with our users and professionals in DfE (Department for Education). Our …| dfedigital.blog.gov.uk
The FDA's 2024 draft guidance emphasizes the critical role of independent DMCs in clinical trials, enhancing oversight, safety, and trial integrity.| Advarra - Advancing Better Research